Influence of Alcohol Consumption on Adherence to and Toxicity of Antiretroviral Therapy and Survival

September 2010
Alcohol Research & Health;2010, Vol. 33 Issue 3, p280
Academic Journal
Antiretroviral therapy (ART) has substantially altered the fate of HIV-infected people, transforming the infection from an invariably fatal disease to a chronic condition manageable by pharmacotherapy. However, in order for ART to be effective, patients must adhere strictly to an often-demanding treatment regimen. Alcohol consumption may impact survival of HIV-infected patients through a variety of pathways. Some of these are not related to the effectiveness of ART (e.g., alcohol-induced immunosuppression that exacerbates the HIV-related immunosuppression, increased hepatotoxicity, and increased mortality from non-HIV-related causes). However, some pathways mediating alcohol's negative effect on survival are related to ART effectiveness. In particular, alcohol consumption may reduce adherence to ART, leading to decreased ART effectiveness and, ultimately, increased HIV-related mortality. Both clinical data and computer simulations have yielded information about the impact of alcohol consumption on medication adherence in both HIV-infected and noninfected patients. The findings suggest that alcohol-related nonadherence may account for a substantial amount of preventable mortality among HIV-infected patients. These findings may have clinical implications with respect to optimal treatment for HIV-infected patients who also consume alcohol.


Related Articles

  • Viral Suppression and Antiretroviral Medication Adherence Among Alcohol Using HIV-Positive Adults. Kalichman, Seth; Grebler, Tamar; Amaral, Christina; McNerney, Megan; White, Denise; Kalichman, Moira; Cherry, Chauncey; Eaton, Lisa // International Journal of Behavioral Medicine;Oct2014, Vol. 21 Issue 5, p811 

    Background: Substance use is a known predictor of poor adherence to antiretroviral therapies (ART) in people living with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome. Less studied is the association between substance use and treatment outcomes, namely, suppression of HIV...

  • Abstracts from current global literature: ART resistance in reference to Indian population. Jain, Sonia // Indian Journal of Sexually Transmitted Diseases;Jan-Jun2013, Vol. 34 Issue 1, p53 

    The article presents abstracts on the antiretroviral treatment (ART) resistance in reference to Indian population including the association between HIV-1 subtype antiretroviral resistance and human leukocyte antigen (HLA) prevalence, HIV drug resistance and viremia resistance mutations.

  • Alcohol use, antiretroviral therapy adherence, and preferences regarding an alcohol-focused adherence intervention in patients with human immunodeficiency virus. Kekwaletswe, Connie T.; Morojele, Neo K. // Patient Preference & Adherence;2014, Vol. 8, p401 

    Background: The primary objectives of this study were to determine the association between alcohol and antiretroviral therapy (ART) adherence and the perceived appropriateness and acceptability of elements of an adherence counseling program with a focus on alcohol-related ART nonadherence among...

  • Psychological predictors for attendance of post-HIV test counselling and linkage to care: the Umeed cohort study in Goa, India. Mayston, Rosie; Patel, Vikram; Abas, Melanie; Korgaonkar, Priya; Paranjape, Ramesh; Rodrigues, Savio; Prince, Martin // BMC Psychiatry;2014, Vol. 14 Issue 1, p377 

    Background Successful linkage to care is increasingly recognised as a potentially important factor in determining the success of Antiretroviral Therapy treatment programmes. However, the role of psychological factors during the early part of the continuum of care has so far been...

  • Pre exposure Prophylaxis for HIV: A Good Idea?  // School Health Alert;Dec2012, Vol. 28 Issue 4, p7 

    The article focuses on the first drug approved by the U.S. Food and Drug Administration (FDA) called Truvada, which can be prescribed to sexually-active people to prevent transmission of the HIV. Clinical trials show only 75% effectiveness of Truvada in reducing the risk of HIV acquisition...

  • Estrategias farmacológicas para facilitar la adherencia a la terapia antirretroviral altamente activa. Clapé-Laffita, Oneyda // Revista Medica del IMSS;2013, Vol. 51 Issue 2, p200 

    Background: adherence to antiretroviral therapy is an important factor in achieving human immunodeficiency virus suppression. The aim was to apply a pharmacological strategy, based in pharmacokinetics measures for improving the adherence to antiretroviral therapy. Methods: We did a descriptive...

  • Where to Start?  // Guide;May2006, Vol. 26 Issue 5, p77 

    The article states that the use of antiretroviral therapy for HIV patients still faces challenges, such as major adverse effects, difficulties of patients to comply with treatment regimen, and antiretroviral drug resistance. Patients are encouraged to visit www.hivinsite.org to obtain...

  • How HIV Treatment Failure Occurs Without Resistance. Breindl, Anette // BioWorld Today;9/5/2012, Vol. 23 Issue 172, p1 

    The article reports on a mathematical model developed by scientists which may be able to help determine the best way to prevent resistance to currently available HIV drugs and identify effective combinations of new drugs early on in clinical development. According to Alison Hill of Harvard...

  • Modifying Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients. Collins, Sean; Grant, Philip; Shafer, Robert // Drugs;Jan2016, Vol. 76 Issue 1, p75 

    HIV-1-infected patients with suppressed plasma viral loads often require changes to their antiretroviral (ARV) therapy to manage drug toxicity and intolerance, to improve adherence, and to avoid drug interactions. In patients who have never experienced virologic failure while receiving ARV...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics